Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesAdipose Tissue as a Modulator of Clinical Inflammation: Does Obesity Reduce the Prevalence of Rheumatoid Arthritis?
Journal of Rheumatology, 03/02/07
Tamas Bartfai, et al. - Conclusion: Although both RA and obesity have been reported to be characterized by high serum levels of inflammatory cytokines, the frequency of one disorder was not increased in the other. We propose that the lack of association in prevalence between the 2 inflammatory states, rather than reflecting a post-hoc effect of the disease on BMI, is a function of the relative amounts of pro- and antiinflammatory mediators produced in adipose tissue, which under many circumstances leads to an overall systemic antiinflammatory tone
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Minimally invasive and conventional glucose monitoring did not differ for long-term glycaemic control in insulin-treated diabetes
Evidence-Based Medicine, 12/07/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Review: intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes
Evidence-Based Medicine, 12/07/09
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of joint lavage in knee osteoarthritis: Meta-analysis of randomized controlled studies
Rheumatology, 12/07/09
Interferon-[alpha] mediates suppression of C-reactive protein: Explanation for muted C-reactive protein response in lupus flares?
Arthritis & Rheumatism, 12/07/09
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor